Mary Elizabeth Strek to Endothelin A Receptor Antagonists
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Endothelin A Receptor Antagonists.
Connection Strength
0.114
-
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med. 2013 May 07; 158(9):641-9.
Score: 0.114
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.